Solving a Novel Multidrug Resistance Puzzle: Complete Loss of Lipooligosaccharide
Solving a Novel Multidrug Resistance Puzzle: Complete Loss of Lipooligosaccharide
批准号:
8833481
负责人:
Joseph Michael Boll
金额:
$5.24万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-03-01 至 2017-02-28
关键词:
Acinetobacter baumanniiAnabolismAntibiotic ResistanceAntibiotic TherapyAntibioticsAptitudeArchitectureBacteriaBacterial InfectionsBasic ScienceBindingBiological AssayBloodCell DeathCell Membrane PermeabilityCell SurvivalCellsCiprofloxacinClinicalColistinCommunitiesCoupledCytolysisDevelopmentDrug resistanceExposure toExtravasationFutureGenesGeneticGlycerophospholipidsGram-Negative BacteriaHealthcareHigh-Throughput Nucleotide SequencingInfectionKnowledgeLaboratoriesLeadLifeLipid ALipopolysaccharide Biosynthesis PathwayLipopolysaccharidesMedicalMembraneMembrane ProteinsMolecularMulti-Drug ResistanceMutagenesisMutationNosocomial InfectionsNucleotidesPathway interactionsPatientsPeptidesPermeabilityPhenotypePhospholipidsPneumoniaPolymyxin ResistancePolymyxinsPolysaccharidesPredispositionPublic HealthResistanceResistance developmentResortSequence AnalysisSurfaceSurgical woundUrinary tract infectionVaccinesVariantWorkantimicrobialantimicrobial drugcapsuleclinically relevantcolistin resistancegenome sequencingimprovedinorganic phosphatelipooligosaccharidenext generation sequencingnovelnovel therapeuticspathogenpreventpublic health relevanceresistance generesistance mechanismtigecycline
中文摘要
英文摘要
DESCRIPTION (provided by applicant): Bacterial pathogens exploit various molecular mechanisms to survive unpredictable and adverse environmental conditions. Gram-negative bacteria often alter their environmentally exposed outer membrane, an asymmetric bilayer consisting of inner leaflet glycerophospholipids and essential outer leaflet lipooligosaccharide or
lipopolysaccharide. Acinetobacter baumannii is a Gram-negative nosocomial pathogen that thrives in healthcare settings because of its ability to develop resistance to antibiotics. Multidrg resistant A. baumannii have become widespread over the past decade and last-line antibiotics such as colistin, which target the essential lipooligosaccharide in the outer membrane, have been increasingly prescribed to treat multidrug resistant infections. While colistin resistance was
once rare, this is no longer the case, especially regarding A. baumannii. Uniquely, A. baumannii can completely shut down lipopolysaccharide biosynthesis to develop resistance to colistin and many other commonly prescribed antibiotics. This finding is surprising because lipooligosaccharide and lipopolysaccharide were previously thought to be required for Gram-negative bacterial viability, but this multidrug resistance mechanism proves that it is not essential. Mechanisms that contribute to this multidrug resistance phenotype are not understood and treatment options have not been explored. The overall objective of this proposal is to characterize and understand a novel multidrug resistance mechanism. The Specific Aims of this proposal are (i) to understand the genetic requirements for complete loss of lipooligosaccharide and (ii) to characterize the altered outer membrane permeability barrier after complete loss of lipooligosaccharide. Completion of this work will contribute an essential body of knowledge to the essentiality of lipooligosaccharide or lipopolysaccharide in Gram-negative bacteria and provide understanding of a molecular mechanism required for a novel multidrug resistance mechanism. The basic science framework from this proposal could also potentially lead to development of novel therapeutics and improved vaccines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanistic basis of how LD-transpeptidases protect against outer membrane defects
-
批准号:10586069
-
项目类别:
-
资助金额:$28.87万
-
财政年份:2022
-
负责人:Joseph Michael Boll
-
依托单位:
Reinforcing the barrier: Understanding how cell envelope modifications promote intrinsic antimicrobial tolerance and resistance in Acinetobacter baumannii
-
批准号:10437019
-
项目类别:
-
资助金额:$36.66万
-
财政年份:2021
-
负责人:Joseph Michael Boll
-
依托单位:
Reinforcing the barrier: Understanding how cell envelope modifications promote intrinsic antimicrobial tolerance and resistance in Acinetobacter baumannii
-
批准号:10605318
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Joseph Michael Boll
-
依托单位:
Reinforcing the barrier: Understanding how cell envelope modifications promote intrinsic antimicrobial tolerance and resistance in Acinetobacter baumannii
-
批准号:10880873
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2021
-
负责人:Joseph Michael Boll
-
依托单位:
Reinforcing the barrier: Understanding how cell envelope modifications promote intrinsic antimicrobial tolerance and resistance in Acinetobacter baumannii
-
批准号:10276854
-
项目类别:
-
资助金额:$36.66万
-
财政年份:2021
-
负责人:Joseph Michael Boll
-
依托单位:
Solving a Multidrug Resistance Puzzle: Complete Loss of Lipooligosaccharide
-
批准号:9808273
-
项目类别:
-
资助金额:$20.37万
-
财政年份:2019
-
负责人:Joseph Michael Boll
-
依托单位:
海外基金